Comments
Loading...

Gilead Sciences Stock Guidance

GILDNASDAQ
Logo brought to you by Benzinga Data
$118.78
-1.00-0.83%
At close: Dec 16, 4:00 PM EST
$118.78
N/A
After Hours: 5:41 PM EST
The dividend Ex-Date was 1 day ago

Gilead Sciences Stock Guidance | NASDAQ:GILD | Benzinga

Gilead Sciences issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Get Alert
10/30/2025GILD
Gilead Sciences
FY2025$8.05$8.25$8.05$28.40B$28.70B$28.83BGet Alert
08/07/2025GILD
Gilead Sciences
FY2025$7.95$8.25$8.01$28.30B$28.70B$28.71BGet Alert
04/24/2025GILD
Gilead Sciences
FY2025$7.70$8.10$7.95$28.20B$28.60B$28.73BGet Alert
02/11/2025GILD
Gilead Sciences
FY2025$7.70$8.10$7.60$28.20B$28.60B$28.41BGet Alert
11/06/2024GILD
Gilead Sciences
FY2024$4.25$4.45$3.81$27.80B$28.10B$27.72BGet Alert
08/08/2024GILD
Gilead Sciences
FY2024$3.60$3.90$3.75$27.10B$27.50B$27.58BGet Alert
04/25/2024GILD
Gilead Sciences
FY2024$3.45$3.85$3.67$27.10B$27.50B$25.69BGet Alert
02/06/2024GILD
Gilead Sciences
FY2024$6.85$7.25$7.21$27.10B$27.50B$27.66BGet Alert
11/07/2023GILD
Gilead Sciences
FY2023$6.65$6.85$6.25$26.70B$26.90B$25.34BGet Alert
08/03/2023GILD
Gilead Sciences
FY2023$6.45$6.80$6.73$26.30B$26.70B$26.66BGet Alert
04/27/2023GILD
Gilead Sciences
FY2023$6.60$7.00$6.84$26.00B$26.50B$26.73BGet Alert
02/02/2023GILD
Gilead Sciences
FY2023$6.60$7.00$6.73$26.00B$26.50B$25.76BGet Alert
10/27/2022GILD
Gilead Sciences
FY2022$6.95$7.15$6.54$25.90B$26.20B$25.25BGet Alert
08/02/2022GILD
Gilead Sciences
FY2022$6.35$6.75$6.57$24.50B$25.00B$24.57BGet Alert
04/28/2022GILD
Gilead Sciences
FY2022$6.20$6.70$6.50$23.80B$24.30B$24.48BGet Alert
02/01/2022GILD
Gilead Sciences
FY2022$6.20$6.70$6.91$23.80B$24.30B$24.39BGet Alert

FAQ

Q

What is the most recent guidance for Gilead Sciences (GILD)?

A

The most recent guidance for Gilead Sciences (GILD) was reported on October 30, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $8.05 to $8.25, compared to the estimated EPS of $8.05. Additionally, Gilead Sciences forecasted revenue between $28.40B and $28.70B for the quarter.

Browse guidance and forecast on all stocks.